See the DrugPatentWatch profile for Cisplatin
The patent for cisplatin, a chemotherapy drug, was filed in 1979. [1]
When does the patent for cisplatin expire?
The original patent for cisplatin was filed in 1979, and its term has since expired. [1] This means that generic versions of cisplatin are available.
What is cisplatin used for?
Cisplatin is a chemotherapy medication used to treat a variety of cancers, including testicular cancer, bladder cancer, ovarian cancer, and lung cancer. [2] It works by interfering with the growth of cancer cells and causing them to die. [3]
How is cisplatin administered?
Cisplatin is typically administered intravenously, meaning it is given through a needle inserted into a vein. [4] It is often used in combination with other chemotherapy drugs as part of a treatment regimen. [5]
What are the side effects of cisplatin?
Like other chemotherapy drugs, cisplatin can cause side effects. Common side effects include nausea, vomiting, hair loss, and fatigue. [6] More serious side effects can include kidney damage, nerve damage, and hearing loss. [7]
Who developed cisplatin?
Cisplatin was discovered by Barnett Rosenberg and his colleagues at Michigan State University in the 1960s. [8] Their research showed that an electric current applied to a platinum wire could stimulate bacterial cell division, leading to the discovery that platinum compounds could kill cancer cells. [8]
Are there alternatives to cisplatin?
For certain types of cancer, alternative chemotherapy drugs or treatment modalities may be available. The choice of treatment depends on the specific cancer, its stage, and the patient's overall health. [9]
What is the regulatory status of cisplatin?
Cisplatin is an approved medication by regulatory bodies like the U.S. Food and Drug Administration (FDA) for the treatment of various cancers. [10]
Sources:
[1] DrugPatentWatch.com
[2] National Cancer Institute
[3] American Cancer Society
[4] Mayo Clinic
[5] Cancer.Net
[6] Cleveland Clinic
[7] WebMD
[8] Michigan State University
[9] U.S. National Library of Medicine
[10] U.S. Food and Drug Administration